196 related articles for article (PubMed ID: 23021715)
1. Hyperthermic intraperitoneal chemotherapy: methodology and safety considerations.
González-Moreno S; González-Bayón L; Ortega-Pérez G
Surg Oncol Clin N Am; 2012 Oct; 21(4):543-57. PubMed ID: 23021715
[TBL] [Abstract][Full Text] [Related]
2. Anesthesia considerations during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Rothfield KP; Crowley K
Surg Oncol Clin N Am; 2012 Oct; 21(4):533-41. PubMed ID: 23021714
[TBL] [Abstract][Full Text] [Related]
3. Patient selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, and role of laparoscopy in diagnosis, staging, and treatment.
Valle M; Federici O; Garofalo A
Surg Oncol Clin N Am; 2012 Oct; 21(4):515-31. PubMed ID: 23021713
[TBL] [Abstract][Full Text] [Related]
4. Drugs, carrier solutions and temperature in hyperthermic intraperitoneal chemotherapy.
Kusamura S; Dominique E; Baratti D; Younan R; Deraco M
J Surg Oncol; 2008 Sep; 98(4):247-52. PubMed ID: 18726886
[TBL] [Abstract][Full Text] [Related]
5. Current status and future directions in the treatment of peritoneal dissemination from colorectal carcinoma.
Elias D; Quenet F; Goéré D
Surg Oncol Clin N Am; 2012 Oct; 21(4):611-23. PubMed ID: 23021719
[TBL] [Abstract][Full Text] [Related]
6. Volume therapy and cardiocircular function during hyperthermic intraperitoneal chemotherapy.
Raue W; Tsilimparis N; Bloch A; Menenakos C; Hartmann J
Eur Surg Res; 2009; 43(4):365-72. PubMed ID: 19844110
[TBL] [Abstract][Full Text] [Related]
7. Randomized clinical trials for colorectal cancer peritoneal surface malignancy.
Avital I; Brücher BL; Nissan A; Stojadinovic A
Surg Oncol Clin N Am; 2012 Oct; 21(4):665-88. PubMed ID: 23021723
[TBL] [Abstract][Full Text] [Related]
8. Techniques and Safety Issues for Intraperitoneal Chemotherapy.
González-Moreno S; Ortega-Pérez G; Alonso-Casado O; Galipienzo-García J; Linero-Noguera MJ; Salvatierra-Díaz D
Surg Oncol Clin N Am; 2018 Jul; 27(3):495-506. PubMed ID: 29935685
[TBL] [Abstract][Full Text] [Related]
9. Current status and future directions in appendiceal cancer with peritoneal dissemination.
Votanopoulos KI; Shen P; Stewart JH; Levine EA
Surg Oncol Clin N Am; 2012 Oct; 21(4):599-609. PubMed ID: 23021718
[TBL] [Abstract][Full Text] [Related]
10. Cytoreductive surgery associated to hyperthermic intraperitoneal chemoperfusion for desmoplastic round small cell tumor with peritoneal carcinomatosis in young patients.
Msika S; Gruden E; Sarnacki S; Orbach D; Philippe-Chomette P; Castel B; Sabaté JM; Flamant Y; Kianmanesh R
J Pediatr Surg; 2010 Aug; 45(8):1617-21. PubMed ID: 20713209
[TBL] [Abstract][Full Text] [Related]
11. Early intervention for treatment and prevention of colorectal carcinomatosis: a plan for individualized care.
Sugarbaker PH
Surg Oncol Clin N Am; 2012 Oct; 21(4):689-703. PubMed ID: 23021724
[TBL] [Abstract][Full Text] [Related]
12. Safety and potential benefit of hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal carcinomatosis from primary or recurrent ovarian cancer.
Roviello F; Pinto E; Corso G; Pedrazzani C; Caruso S; Filippeschi M; Petrioli R; Marsili S; Mazzei MA; Marrelli D
J Surg Oncol; 2010 Nov; 102(6):663-70. PubMed ID: 20721959
[TBL] [Abstract][Full Text] [Related]
13. The importance of the learning curve and surveillance of surgical performance in peritoneal surface malignancy programs.
Kusamura S; Baratti D; Hutanu I; Rossi P; Deraco M
Surg Oncol Clin N Am; 2012 Oct; 21(4):559-76. PubMed ID: 23021716
[TBL] [Abstract][Full Text] [Related]
14. [Peritoneal carcinomatosis of colorectal cancer: cytoreductive surgery and hyperthermic intraperitoneal chemotherapy].
Königsrainer I; Beckert S; Brücher B; Zieker D; Königsrainer A
Dtsch Med Wochenschr; 2011 Sep; 136(36):1811-4. PubMed ID: 21882140
[TBL] [Abstract][Full Text] [Related]
15. Pharmacology of perioperative intraperitoneal and intravenous chemotherapy in patients with peritoneal surface malignancy.
Van der Speeten K; Stuart OA; Sugarbaker PH
Surg Oncol Clin N Am; 2012 Oct; 21(4):577-97. PubMed ID: 23021717
[TBL] [Abstract][Full Text] [Related]
16. Reported impact of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on systemic toxicity.
Sugarbaker PH
Ann Surg Oncol; 2008 Jun; 15(6):1800-1; author reply 1802-3. PubMed ID: 18196342
[No Abstract] [Full Text] [Related]
17. Hyperthermic intraperitoneal chemotherapy: nomenclature and modalities of perfusion.
Glehen O; Cotte E; Kusamura S; Deraco M; Baratti D; Passot G; Beaujard AC; Noel GF
J Surg Oncol; 2008 Sep; 98(4):242-6. PubMed ID: 18726885
[TBL] [Abstract][Full Text] [Related]
18. Cytoreductive surgery and intraoperative hyperthermic intraperitoneal chemotherapy with paclitaxel: a clinical and pharmacokinetic study.
de Bree E; Rosing H; Filis D; Romanos J; Melisssourgaki M; Daskalakis M; Pilatou M; Sanidas E; Taflampas P; Kalbakis K; Beijnen JH; Tsiftsis DD
Ann Surg Oncol; 2008 Apr; 15(4):1183-92. PubMed ID: 18239973
[TBL] [Abstract][Full Text] [Related]
19. Hyperthermic intraperitoneal chemotherapy with and without cytoreductive surgery for epithelial ovarian cancer.
Helm CW; Bristow RE; Kusamura S; Baratti D; Deraco M
J Surg Oncol; 2008 Sep; 98(4):283-90. PubMed ID: 18726895
[TBL] [Abstract][Full Text] [Related]
20. Current status and future directions of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of ovarian cancer.
Helm CW
Surg Oncol Clin N Am; 2012 Oct; 21(4):645-63. PubMed ID: 23021722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
